Expert NetworkExpert InterviewCRSP

Slingshot members are talking to an expert! The topic is:

Discussing CRISPR Therapeutics Phase 1 Trial of their CRISPR-Cas9 Gene Editing Treatment, CTX310, Targeting ANGPTL3 and its Potential in Cardiovascular Disease

Executed on:Dec 10, 2025 2:30 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Penn Medicine
  • Cardiologist affiliated with Penn Medicine / Penn Presbyterian Medical Center and Virtua hospitals in the region. 
  • Manages 2500 patients with hyperlipidemia 
  • Serves also as Clinical Associate Professor of Medicine and directs the Penn Cardiology Anticoagulation Clinic in Cherry Hill, combining clinical care, teaching, and specialized cardiovascular management.

Interview Goal

This interview aims to speak on the potential of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 in CVD management.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.